{"nct_id":"NCT01492088","title":"Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2012-04-16","start_date_type":"ACTUAL","primary_completion_date":"2016-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TAK"]}